Vault-13

BML Capital Management, LLC

ZIONSVILLE, IN · CIK 1616824 · 13F filing filed 2026-08-07

Exempt reporting adviser since 2012 · limited liability company

As an employer

$175.1m reported value +12.7% vs Q1 2026
15positions
93.8%in top 10
1 new 5 added 3 reduced 1 sold out vs Q1 2026

Options: 0 call positions (— notional), 3 put positions ($954.1k notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ACLARIS THERAPEUTICS INC COM ACRS ACRS 11,975,000 $63.3m36.18% 36.18% ReducedShares held: Q3 2025 14.2m, Q4 2025 14.2m, Q1 2026 14.2m, Q2 2026 12.0m -2.3m -2,275,000 -16.0%
2 ATEA PHARMACEUTICALS INC COM AVIR AVIR 6,952,330 $32.3m18.46% 18.46% ReducedShares held: Q3 2025 7.5m, Q4 2025 7.5m, Q1 2026 7.1m, Q2 2026 7.0m -106.3k -106,327 -1.5%
3 ENGENE THERAPEUTICS INC COM ENGN ENGN 6,669,908 $11.5m6.59% 6.59% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.7m
4 KRAFT HEINZ CO COM KHC KHC 465,000 $11.0m6.27% 6.27% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 125.0k, Q2 2026 465.0k +340.0k +340,000 272.0%
5 OUTSET MED INC COM NEW OM OM 2,519,701 $10.9m6.22% 6.22% AddedShares held: Q3 2025 0, Q4 2025 543.2k, Q1 2026 1.9m, Q2 2026 2.5m +617.5k +617,500 32.5%
6 CARMAX INC COM KMX KMX 172,500 $9.1m5.21% 5.21% AddedShares held: Q3 2025 0, Q4 2025 155.0k, Q1 2026 155.0k, Q2 2026 172.5k +17.5k +17,500 11.3%
7 TILLYS INC CL A TLYS TLYS 2,150,000 $9.0m5.16% 5.16% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.1m, Q2 2026 2.1m
8 PMV PHARMACEUTICALS INC COM PMVP PMVP 5,330,000 $7.1m4.08% 4.08% AddedShares held: Q3 2025 5.3m, Q4 2025 5.3m, Q1 2026 5.3m, Q2 2026 5.3m +10.0k +10,000 0.2%
9 INSTIL BIO INC COM NEW TIL TIL 645,600 $5.0m2.84% 2.84% UnchangedShares held: Q3 2025 645.6k, Q4 2025 645.6k, Q1 2026 645.6k, Q2 2026 645.6k
10 TARGET CORP COM TGT TGT 37,500 $4.9m2.80% 2.80% UnchangedShares held: Q3 2025 10.0k, Q4 2025 37.5k, Q1 2026 37.5k, Q2 2026 37.5k
11 ORAMED PHARMACEUTICALS INC COM NEW ORMP ORMP 866,269 $4.2m2.38% 2.38% ReducedShares held: Q3 2025 3.2m, Q4 2025 3.2m, Q1 2026 3.2m, Q2 2026 866.3k -2.3m -2,300,962 -72.7%
12 JANUX THERAPEUTICS INC COM JANX JANX 154,961 $2.4m1.36% 1.36% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 155.0k, Q2 2026 155.0k
13 PLIANT THERAPEUTICS INC COM PLRX PLRX 1,546,137 $1.8m1.01% 1.01% UnchangedShares held: Q3 2025 0, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.5m
14 CONNECT BIOPHARMA HLDGS LTD SHS CNTB CNTB 573,287 $1.4m0.78% 0.78% AddedShares held: Q3 2025 1.3m, Q4 2025 408.9k, Q1 2026 408.9k, Q2 2026 573.3k +164.4k +164,400 40.2%
15 IMAGENEBIO INC COM IMA IMA 200,730 $1.2m0.68% 0.68% UnchangedShares held: Q3 2025 182.5k, Q4 2025 177.0k, Q1 2026 200.7k, Q2 2026 200.7k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
KEZAR LIFE SCIENCES INC KZR KZR 720,787 $5.3m720.8k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
WALMART INC WMT · Put WMTPut 335 $386.1k335 shares Unchanged
CORE SCIENTIFIC INC NEW CORZ · Put CORZPut 800 $298.0k800 shares New
TESLA INC TSLA · Put TSLAPut 375 $270.0k375 shares New